USARAD Holdings, Inc. Including Its SecondOpinions.Com® Division, Partners with Rcadia Medical Solutions and Launches Fully Automated Cardiac CT Imaging Platform

Share Article

USARAD continues its expansion into the arena of Deep Learning, Artificial Intelligence and Computer Assisted Healthcare

Automated Coronary Image Analysis

By bringing this new service to participating medical facilities and consumers alike we can improve and streamline patient care, decrease healthcare costs and most importantly, save many lives!

FORT LAUDERDALE, Fla. Nov. 30, 2015 /PRWeb/ -- USARAD Holdings Inc., a leading US Joint Commission Accredited telemedicine, second opinions and radiology services solutions provider and Rcadia Medical Solutions, a deep learning applications and software company specializing in Cardiac CT imaging announce strategic collaboration to deliver first of its kind automated cloud-based Cardiac CT Imaging program to patients as well as imaging facilities globally. The service is available via both consumer platform and USARAD proprietary teleradiology platform, either as a level 1 fully automated or level 2 professional interpretation service.

Level 1 service analysis reports are available for hospitals and other medical facilities. B2B customers upload CT images with ease and for a nominal fee receive fully automated preliminary analysis reports generated by the platform. FDA approved Rcadia’s COR Analyzer platform recognizes the CT data and launches a sophisticated analysis process, which provides patient results and a detailed visualization of the findings. Without any human interaction, the platform automatically reports all of the findings in the form of curved MPR images with marked lesions, degree of stenosis and a clinical summary. For multiphase studies, the COR Analyzer automatically selects the best phase for each blood vessel and indicates which phase was used in the analysis. Level 1 service is available for imaging facilities as a free service on a trial basis.

As an optional level 2 service, final interpretation reports are available to both consumers and medical facilities. This service is provided by professional USARAD cardiac imaging team represented by both radiologists and cardiologists who are ACC level III certified or Board Certified in Cardiovascular CT by the Certification Board of Cardiovascular CT. Augmented by the unique platform, cardiac imaging physicians are available to provide accurate and quick emergent and non-emergent cardiac CTA interpretations on a preliminary and final basis, day or night. The service is available World-Wide and is currently being utilized by individual patients in over 60 countries as well as hospitals and other medical facilities within the USA, China, Singapore, UAE, KSA, Russia, Nigeria and many others. Sample level 2 report:

The companies tackle a critically important global healthcare problem. Heart disease is the leading cause of death for both men and women world-wide. According to CDC 1 in every 4 deaths in the United States every year is due to heart disease. Specifically, coronary heart disease which is the most common type kills over 370,000 people annually. Furthermore, every year over 700,000 Americans have a heart attack, many of whom become chronically ill or disabled. Of these patients, over half a million suffer their first heart attack, many of whom do not have any warning signs.

"By bringing this new service to participating medical facilities and consumers alike we can improve and streamline patient care, decrease healthcare costs and most importantly, save many lives. We are very excited about this partnership with Rcadia and positive impact on patients and healthcare as a whole", commented Dr. Michael Yuz, USARAD Holdings Founder and CEO. "This new Cardiac CT platform will allow USARAD and interpreting physicians to accelerate decision making as well as to improve confidence and accuracy of their diagnosis. The platform will also greatly assist facilities with more effective patient management, overall ease of operation, adding to time saving and reduction of hospital admissions by enabling physicians to rule out Acute Coronary Syndrome more quickly”, added Vitaly Sirota, Rcadia’s CEO.

About USARAD Holding Inc. including®
USARAD Holdings, Inc. is a global telemedicine company consisting of two operating divisions – USARAD and®. USARAD is a radiology services provider offering interpretations of a full range of sub-specialty and general radiology patient studies. With an existing advanced technology network connecting medical facilities to board-certified radiologists and support staff, USARAD offers radiology services in all 50 states as well as more than 10 countries. Via its unique Radiology-On-Demand® platform, USARAD is committed to providing timely and responsive image review 24/7.® is a medical consultation and second opinions leader providing health care customers, physicians and consumers with expert opinions from all medical specialties and sub-specialties.®, which currently conducts business in more than 60 countries, also contracts with insurance companies, corporations, and medical centers of excellence. USARAD has recently received funding from the Venture Capital Unit of Siemens, Omphalos Venture Partners and Excelerate Health Ventures. For more information please
Visit and The company is exhibiting at RSNA conference in Chicago Dec 29 to Dec 3rd, Booths 3948 and 3949.

About Rcadia Medical Solutions Ltd.
Rcadia Medical Solutions Ltd. develops and markets proprietary systems for computerized analysis of medical images, particularly for patient triage in, emergency, life threatening conditions. The company’s first FDA approved product - the COR Analyzer® System - performs fully automatic analysis of Coronary CT Angiography (cCTA) studies to identify patients with significant stenosis in the coronary arteries. The COR Analyzer enhances the use of cCTA in the emergency department (ED) to triage chest pain patients and improve radiology and cardiology departments workflow. For more information please visit

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Lorna Backhaus
Visit website